Assessment of the control measures for category A diseases of Animal Health Law: Lumpy Skin Disease
Research output: Contribution to journal › Journal article › Research
Standard
Assessment of the control measures for category A diseases of Animal Health Law: Lumpy Skin Disease. / EFSA Panel on Animal Health and Welfare, ; Nielsen, Søren Saxmose; Alvarez, Julio; Bicout, Dominique Joseph; Calistri, Paolo; Canali, Elisabetta; Drewe, Julian Ashley; Garin-Bastuji, Bruno; Gonzales Rojas, José Luis; Gortázar Schmidt, Christian; Herskin, Mette; Michel, Virginie; Miranda Chueca, Miguel Ángel; Padalino, Barbara; Pasquali, Paolo; Sihvonen, Liisa Helena; Spoolder, Hans; Ståhl, Karl; Velarde, Antonio; Viltrop, Arvo; Winckler, Christoph; De Clercq, Kris; Gubbins, Simon; Klement, Eyal; Stegeman, Jan Arend; Antoniou, Sotiria-Eleni; Aznar, Inma; Broglia, Alessandro; Van der Stede, Yves; Zancanaro, Gabriele; Roberts, Helen Clare.
In: EFSA Journal, Vol. 20, No. 1, e07121, 2022, p. 1-70.Research output: Contribution to journal › Journal article › Research
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Assessment of the control measures for category A diseases of Animal Health Law: Lumpy Skin Disease
AU - EFSA Panel on Animal Health and Welfare, null
AU - Nielsen, Søren Saxmose
AU - Alvarez, Julio
AU - Bicout, Dominique Joseph
AU - Calistri, Paolo
AU - Canali, Elisabetta
AU - Drewe, Julian Ashley
AU - Garin-Bastuji, Bruno
AU - Gonzales Rojas, José Luis
AU - Gortázar Schmidt, Christian
AU - Herskin, Mette
AU - Michel, Virginie
AU - Miranda Chueca, Miguel Ángel
AU - Padalino, Barbara
AU - Pasquali, Paolo
AU - Sihvonen, Liisa Helena
AU - Spoolder, Hans
AU - Ståhl, Karl
AU - Velarde, Antonio
AU - Viltrop, Arvo
AU - Winckler, Christoph
AU - De Clercq, Kris
AU - Gubbins, Simon
AU - Klement, Eyal
AU - Stegeman, Jan Arend
AU - Antoniou, Sotiria-Eleni
AU - Aznar, Inma
AU - Broglia, Alessandro
AU - Van der Stede, Yves
AU - Zancanaro, Gabriele
AU - Roberts, Helen Clare
N1 - https://doi.org/10.2903/j.efsa.2022.7121
PY - 2022
Y1 - 2022
N2 - Abstract EFSA received a mandate from the EC to assess the effectiveness of some of the control measures against diseases included in the Category A list according to Regulation (EU) 2016/429 on transmissible animal diseases (?Animal Health Law?). This opinion belongs to a series of opinions where these control measures are assessed, with this opinion covering the assessment of control measures for Lumpy Skin Disease (LSD). In this opinion, EFSA and the AHAW Panel of experts review the effectiveness of: i) clinical and laboratory sampling procedures, ii) monitoring period and iii) the minimum radius of the protection and surveillance zones, and the minimum length of time that measures should be applied in these zones. The general methodology used for this series of opinions has been published elsewhere; nonetheless, the transmission kernels used for the assessment of the minimum radius of the protection and surveillance zones are shown. Several scenarios for which these control measures had to be assessed were designed and agreed prior to the start of the assessment. The monitoring period was assessed as effective, and based on the transmission kernels available, it was concluded that the protection zone of 20 km radius and the surveillance zone of 50 km radius would comprise > 99% of the transmission from an affected establishment if transmission occurred. Recommendations provided for each of the assessed scenarios aim to support the European Commission in the drafting of further pieces of legislation, as well as for plausible ad hoc requests in relation to LSD.
AB - Abstract EFSA received a mandate from the EC to assess the effectiveness of some of the control measures against diseases included in the Category A list according to Regulation (EU) 2016/429 on transmissible animal diseases (?Animal Health Law?). This opinion belongs to a series of opinions where these control measures are assessed, with this opinion covering the assessment of control measures for Lumpy Skin Disease (LSD). In this opinion, EFSA and the AHAW Panel of experts review the effectiveness of: i) clinical and laboratory sampling procedures, ii) monitoring period and iii) the minimum radius of the protection and surveillance zones, and the minimum length of time that measures should be applied in these zones. The general methodology used for this series of opinions has been published elsewhere; nonetheless, the transmission kernels used for the assessment of the minimum radius of the protection and surveillance zones are shown. Several scenarios for which these control measures had to be assessed were designed and agreed prior to the start of the assessment. The monitoring period was assessed as effective, and based on the transmission kernels available, it was concluded that the protection zone of 20 km radius and the surveillance zone of 50 km radius would comprise > 99% of the transmission from an affected establishment if transmission occurred. Recommendations provided for each of the assessed scenarios aim to support the European Commission in the drafting of further pieces of legislation, as well as for plausible ad hoc requests in relation to LSD.
KW - disease control measures
KW - Lumpy Skin Disease
KW - LSD
KW - sampling procedures
KW - monitoring period
KW - protection zone
KW - surveillance zone
U2 - 10.2903/j.efsa.2022.7121
DO - 10.2903/j.efsa.2022.7121
M3 - Journal article
C2 - 35106095
VL - 20
SP - 1
EP - 70
JO - E F S A Journal
JF - E F S A Journal
SN - 1831-4732
IS - 1
M1 - e07121
ER -
ID: 290594419